-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Guardant Health, Raises Price Target to $215

Benzinga·07/08/2026 16:05:00
Listen to the news
Citigroup analyst Patrick Donnelly maintains Guardant Health (NASDAQ:GH) with a Buy and raises the price target from $150 to $215.